The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Niacin Cures Systemic NAD+ Deficiency and Improves Muscle Performance in Adult-Onset Mitochondrial Myopathy
Open accessAbstract
NAD+ is a redox-active metabolite, the depletion of which has been proposed to promote aging and degenerative diseases in rodents. However, whether NAD+ depletion occurs in patients with degenerative disorders and whether NAD+ repletion improves their symptoms has remained open. Here, we report systemic NAD+ deficiency in adult-onset mitochondrial myopathy patients. We administered an increasing dose of NAD+-booster niacin, a vitamin B3 form (to 750-1,000 mg/day; clinicaltrials.govNCT03973203) for patients and their matched controls for 10 or 4 months, respectively. Blood NAD+ increased in all subjects, up to 8-fold, and muscle NAD+ of patients reached the level of their controls. Some patients showed anemia tendency, while muscle strength and mitochondrial biogenesis increased in all subjects. In patients, muscle metabolome shifted toward controls and liver fat decreased even 50%. Our evidence indicates that blood analysis is useful in identifying NAD+ deficiency and points niacin to be an efficient NAD+ booster for treating mitochondrial myopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
HTSeq—a Python framework to work with high-throughput sequencing data
Anders, S., Pyl, P. T., & Huber, W. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu638 · Cited by 21,464
MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis
Chong, J., Soufan, O., Li, C., Caraus, I., Li, S., Bourque, G., Wishart, D. S., & Xia, J. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky310 · Cited by 3,629
Mitochondria: In Sickness and in Health
Nunnari, J., & Suomalainen, A. (2012) · Cell · doi:10.1016/j.cell.2012.02.035 · Cited by 3,479
Self-citationCantó, C., Menzies, K. J., & Auwerx, J. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.023 · Cited by 1,648 · cited 5×
“…and cluster of differentiation 38) (Cantó et al., 2015; Pirinen et al., 2014), NAD+ precursor supplementation (Bieganowski and Brenner, 2004; Cantó et al., 2015), or by inhibition of aminocarboxymuconate semialdehyde decarboxylase (Katsyuba et al., 2018), which results in increased de…”
BackgroundInfluentialImproved Method for Accurate and Efficient Quantification of MRS Data with Use of Prior Knowledge
Vanhamme, L., van den Boogaart, A., & Van Huffel, S. (1997) · Journal of Magnetic Resonance · doi:10.1006/jmre.1997.1244 · Cited by 1,627
Yoshino, J., Mills, K. F., Yoon, M. J., & Imai, S.-I. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.014 · Cited by 1,340
NAD + repletion improves mitochondrial and stem cell function and enhances life span in mice
Zhang, H., Ryu, D., Wu, Y., Gariani, K., Wang, X., Luan, P., D’Amico, D., Ropelle, E. R., Lutolf, M. P., Aebersold, R., et al. (2016) · Science · doi:10.1126/science.aaf2693 · Cited by 1,255 · cited 4×
“The revelation of disturbed NAD homeostasis in muscle and metabolic diseases (Gariani et al., 2016; Khan et al., 2014; Ryu et al., 2016; Trammell et al., 2016; Yoshino et al., 2011; Zhang et al., 2016) in animals has generated a high interest whether NAD metabolism aberrations occur in degenerative diseases in humans…”
BackgroundInfluentialNAD+ metabolism in health and disease
Belenky, P., Bogan, K. L., & Brenner, C. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.11.006 · Cited by 981
Self-citationSpelbrink, J. N., Li, F.-Y., Tiranti, V., Nikali, K., Yuan, Q.-P., Tariq, M., Wanrooij, S., Garrido, N., Comi, G., Morandi, L., et al. (2001) · Nature Genetics · doi:10.1038/90058 · Cited by 882
Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence
Rajman, L., Chwalek, K., & Sinclair, D. A. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.02.011 · Cited by 865
Van Goethem, G., Dermaut, B., Löfgren, A., Martin, J.-J., & Van Broeckhoven, C. (2001) · Nature Genetics · doi:10.1038/90034 · Cited by 841
Prediction of Non-Alcoholic Fatty Liver Disease and Liver Fat Using Metabolic and Genetic Factors
Kotronen, A., Peltonen, M., Hakkarainen, A., Sevastianova, K., Bergholm, R., Johansson, L. M., Lundbom, N., Rissanen, A., Ridderstråle, M., Groop, L., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.005 · Cited by 804
Self-citationAnalyzing gene expression data in terms of gene sets: methodological issues
Goeman, J. J., & Bühlmann, P. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm051 · Cited by 802
Bieganowski, P., & Brenner, C. (2004) · Cell · doi:10.1016/s0092-8674(04)00416-7 · Cited by 750
Self-citationMeasurement of intracellular triglyceride stores by H spectroscopy: validation in vivo
Szczepaniak, L. S., Babcock, E. E., Schick, F., Dobbins, R. L., Garg, A., Burns, D. K., McGarry, J. D., & Stein, D. T. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.276.5.e977 · Cited by 688
Zeviani, M., Servidei, S., Gellera, C., Bertini, E., DiMauro, S., & DiDonato, S. (1989) · Nature · doi:10.1038/339309a0 · Cited by 637
Role of Adenine Nucleotide Translocator 1 in mtDNA Maintenance
Kaukonen, J., Juselius, J. K., Tiranti, V., Kyttälä, A., Zeviani, M., Comi, G. P., Keränen, S., Peltonen, L., & Suomalainen, A. (2000) · Science · doi:10.1126/science.289.5480.782 · Cited by 636
Self-citationCharacterization of human high-density lipoproteins by gradient gel electrophoresis
Blanche, P. J., Gong, E. L., Forte, T. M., & Nichols, A. V. (1981) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(81)90253-8 · Cited by 614
Quantitative Analysis of NAD Synthesis-Breakdown Fluxes
Liu, L., Su, X., Quinn, W. J., Hui, S., Krukenberg, K., Frederick, D. W., Redpath, P., Zhan, L., Chellappa, K., White, E., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.03.018 · Cited by 564
Quantitation of magnetic resonance spectroscopy signals: the jMRUI software package
Stefan, D., Cesare, F. D., Andrasescu, A., Popa, E., Lazariev, A., Vescovo, E., Strbak, O., Williams, S., Starcuk, Z., Cabanas, M., et al. (2009) · Measurement Science and Technology · doi:10.1088/0957-0233/20/10/104035 · Cited by 514
Mitochondrial diseases: the contribution of organelle stress responses to pathology
Suomalainen, A., & Battersby, B. J. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.66 · Cited by 505
Self-citationElhassan, Y. S., Kluckova, K., Fletcher, R. S., Schmidt, M. S., Garten, A., Doig, C. L., Cartwright, D. M., Oakey, L., Burley, C. V., Jenkinson, N., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.07.043 · Cited by 448
Self-citationMitochondrial dysfunction remodels one-carbon metabolism in human cells
Bao, X. R., Ong, S.-E., Goldberger, O., Peng, J., Sharma, R., Thompson, D. A., Vafai, S. B., Cox, A. G., Marutani, E., Ichinose, F., et al. (2016) · eLife · doi:10.7554/elife.10575 · Cited by 448
De novo NAD+ synthesis enhances mitochondrial function and improves health
Katsyuba, E., Mottis, A., Zietak, M., De Franco, F., van der Velpen, V., Gariani, K., Ryu, D., Cialabrini, L., Matilainen, O., Liscio, P., et al. (2018) · Nature · doi:10.1038/s41586-018-0645-6 · Cited by 430
Suomalainen, A., Elo, J. M., Pietiläinen, K. H., Hakonen, A. H., Sevastianova, K., Korpela, M., Isohanni, P., Marjavaara, S. K., Tyni, T., Kiuru-Enari, S., et al. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70155-7 · Cited by 427
Self-citationBelenky, P., Racette, F. G., Bogan, K. L., McClure, J. M., Smith, J. S., & Brenner, C. (2007) · Cell · doi:10.1016/j.cell.2007.03.024 · Cited by 411 · cited 4×
“Vitamin B3 is an NAD precursor and exists in several forms: nicotinic acid (niacin), nicotinamide (NAM), and nicotinamide riboside (NR) (Belenky et al., 2007b; Cantó et al., 2015).”
BackgroundInfluentialSelf-citationProton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis
Longo, R., Pollesello, P., Ricci, C., Masutti, F., Kvam, B. J., Bercich, L., Croce, L. S., Grigolato, P., Paoletti, S., De Bernard, B., et al. (1995) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880050311 · Cited by 387
mTORC1 Regulates Mitochondrial Integrated Stress Response and Mitochondrial Myopathy Progression
Khan, N. A., Nikkanen, J., Yatsuga, S., Jackson, C., Wang, L., Pradhan, S., Kivelä, R., Pessia, A., Velagapudi, V., & Suomalainen, A. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.07.007 · Cited by 387
Self-citationEffective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3
Khan, N. A., Auranen, M., Paetau, I., Pirinen, E., Euro, L., Forsström, S., Pasila, L., Velagapudi, V., Carroll, C. J., Auwerx, J., et al. (2014) · EMBO Molecular Medicine · doi:10.1002/emmm.201403943 · Cited by 385
Self-citationGariani, K., Menzies, K. J., Ryu, D., Wegner, C. J., Wang, X., Ropelle, E. R., Moullan, N., Zhang, H., Perino, A., Lemos, V., et al. (2016) · Hepatology · doi:10.1002/hep.28245 · Cited by 368
Migliavacca, E., Tay, S. K. H., Patel, H. P., Sonntag, T., Civiletto, G., McFarlane, C., Forrester, T., Barton, S. J., Leow, M. K., Antoun, E., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13694-1 · Cited by 365
Creatine: Endogenous Metabolite, Dietary, and Therapeutic Supplement
Brosnan, J. T., & Brosnan, M. E. (2007) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.27.061406.093621 · Cited by 347
NAD+-Dependent Activation of Sirt1 Corrects the Phenotype in a Mouse Model of Mitochondrial Disease
Cerutti, R., Pirinen, E., Lamperti, C., Marchet, S., Sauve, A. A., Li, W., Leoni, V., Schon, E. A., Dantzer, F., Auwerx, J., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.04.001 · Cited by 343 · cited 4×
“Niacin Boosts Mitochondrial Biogenesis In mice, NAD boosting improved morphological and molecular hallmarks of mitochondrial myopathy (Cerutti et al., 2014; Khan et al., 2014) when measured by histochemical in situ activities of the respiratory chain enzyme complexes cytochrome c oxidase (COX; respiratory chain comple…”
BackgroundInfluentialSelf-citationNicotinamide Riboside Opposes Type 2 Diabetes and Neuropathy in Mice
Trammell, S. A. J., Weidemann, B. J., Chadda, A., Yorek, M. S., Holmes, A., Coppey, L. J., Obrosov, A., Kardon, R. H., Yorek, M. A., & Brenner, C. (2016) · Scientific Reports · doi:10.1038/srep26933 · Cited by 301 · cited 1×
“The revelation of disturbed NAD homeostasis in muscle and metabolic diseases (Gariani et al., 2016; Khan et al., 2014; Ryu et al., 2016; Trammell et al., 2016; Yoshino et al., 2011; Zhang et al., 2016) in animals has generated a high interest whether NAD metabolism aberrations occur in degenerative diseases in humans…”
BackgroundSelf-citationMitochondrial myopathy induces a starvation-like response
Tyynismaa, H., Carroll, C. J., Raimundo, N., Ahola-Erkkilä, S., Wenz, T., Ruhanen, H., Guse, K., Hemminki, A., Peltola-Mjøsund, K. E., Tulkki, V., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq310 · Cited by 300
Self-citationMitochondrial DNA Replication Defects Disturb Cellular dNTP Pools and Remodel One-Carbon Metabolism
Nikkanen, J., Forsström, S., Euro, L., Paetau, I., Kohnz, R. A., Wang, L., Chilov, D., Viinamäki, J., Roivainen, A., Marjamäki, P., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.01.019 · Cited by 284
Self-citationPrecipitation methods for quantification of lipoproteins
Bachorik, P. S., & Albers, J. J. (1986) · Methods in Enzymology · doi:10.1016/0076-6879(86)29063-1 · Cited by 279
Bruckert, E., Labreuche, J., & Amarenco, P. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.12.023 · Cited by 273
Safety considerations with niacin therapy
Guyton, J. R., & Bays, H. E. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.11.018 · Cited by 269
Kühl, I., Miranda, M., Atanassov, I., Kuznetsova, I., Hinze, Y., Mourier, A., Filipovska, A., & Larsson, N.-G. (2017) · eLife · doi:10.7554/elife.30952 · Cited by 261
Airhart, S. E., Shireman, L. M., Risler, L. J., Anderson, G. D., Nagana Gowda, G. A., Raftery, D., Tian, R., Shen, D. D., & O’Brien, K. D. (2017) · PLOS ONE · doi:10.1371/journal.pone.0186459 · Cited by 259
NAD + repletion improves muscle function in muscular dystrophy and counters global PARylation
Ryu, D., Zhang, H., Ropelle, E. R., Sorrentino, V., Mázala, D. A. G., Mouchiroud, L., Marshall, P. L., Campbell, M. D., Ali, A. S., Knowels, G. M., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf5504 · Cited by 256
Pirinen, E., Cantó, C., Jo, Y. S., Morato, L., Zhang, H., Menzies, K. J., Williams, E. G., Mouchiroud, L., Moullan, N., Hagberg, C., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.04.002 · Cited by 254 · cited 2×
“…approaches, such as decreasing NAD+ consumption (inhibition of poly[ADP-ribose] polymerases and cluster of differentiation 38) (Cantó et al., 2015; Pirinen et al., 2014), NAD+ precursor supplementation (Bieganowski and Brenner, 2004; Cantó et al., 2015), or by inhibition of aminocarboxymuconate…”
BackgroundSelf-citationForsström, S., Jackson, C. B., Carroll, C. J., Kuronen, M., Pirinen, E., Pradhan, S., Marmyleva, A., Auranen, M., Kleine, I.-M., Khan, N. A., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.08.019 · Cited by 252
Self-citationNAD Deficiency, Congenital Malformations, and Niacin Supplementation
Shi, H., Enriquez, A., Rapadas, M., Martin, E. M. M. A., Wang, R., Moreau, J., Lim, C. K., Szot, J. O., Ip, E., Hughes, J. N., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1616361 · Cited by 246
Suomalainen, A., Majander, A., Haltia, M., Somer, H., Lönnqvist, J., Savontaus, M. L., & Peltonen, L. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115856 · Cited by 240
Self-citationFGF21 is a biomarker for mitochondrial translation and mtDNA maintenance disorders
Lehtonen, J. M., Forsström, S., Bottani, E., Viscomi, C., Baris, O. R., Isoniemi, H., Höckerstedt, K., Österlund, P., Hurme, M., Jylhävä, J., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000003374 · Cited by 220
Self-citationRecessive Twinkle mutations in early onset encephalopathy with mtDNA depletion
Hakonen, A. H., Isohanni, P., Paetau, A., Herva, R., Suomalainen, A., & Lonnqvist, T. (2007) · Brain · doi:10.1093/brain/awm242 · Cited by 199
Self-citationTARGETED, LCMS-BASED METABOLOMICS FOR QUANTITATIVE MEASUREMENT OF NAD+ METABOLITES
Trammell, S. A., & Brenner, C. (2013) · Computational and Structural Biotechnology Journal · doi:10.5936/csbj.201301012 · Cited by 192
Self-citationMechanisms of mitochondrial diseases
Ylikallio, E., & Suomalainen, A. (2012) · Annals of Medicine · doi:10.3109/07853890.2011.598547 · Cited by 185
Self-citationMethyl balance and transmethylation fluxes in humans
Mudd, S. H., Brosnan, J. T., Brosnan, M. E., Jacobs, R. L., Stabler, S. P., Allen, R. H., Vance, D. E., & Wagner, C. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.1.19 · Cited by 175
Niacin stimulates adiponectin secretion through the GPR109A receptor
Plaisance, E. P., Lukasova, M., Offermanns, S., Zhang, Y., Cao, G., & Judd, R. L. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.91004.2008 · Cited by 131
Giby, V. G., & Ajith, T. A. (2014) · World Journal of Hepatology · doi:10.4254/wjh.v6.i8.570 · Cited by 128
Taurine and skeletal muscle function
Spriet, L. L., & Whitfield, J. (2014) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000135 · Cited by 110
Extended-release niacin raises adiponectin and leptin
Westphal, S., Borucki, K., Taneva, E., Makarova, R., & Luley, C. H. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.06.028 · Cited by 92
Hu, M., Chu, C. W., Yamashita, S., Yeung, D. K. W., Shi, L., Wang, D., Masuda, D., Yang, Y., & Tomlinson, B. (2012) · Journal of Lipid Research · doi:10.1194/jlr.p023614 · Cited by 88
Determinants of isometric muscle strength in men of different ages
Era, P. A., Lyyra, A., Viitasalo, J. T., et al. (1992) · European Journal of Applied Physiology · doi:10.1007/bf00376446 · Cited by 85
Ganji, S. H., Kukes, G. D., Lambrecht, N. W. G., Kashyap, M. L., & Kamanna, V. S. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00181.2013 · Cited by 85
Niacin: a re‐emerging pharmaceutical for the treatment of dyslipidaemia
Vosper, H. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00349.x · Cited by 81
Bergen, N. J. V., Guo, Y., Rankin, J., Paczia, N., Becker‐Kettern, J., Kremer, L. S., Pyle, A., Conrotte, J., Ellaway, C., Procopis, P., et al. (2018) · Brain · doi:10.1093/brain/awy310 · Cited by 81
Ahola, S., Auranen, M., Isohanni, P., Niemisalo, S., Urho, N., Buzková, J., Velagapudi, V., Lundbom, N. M. I., Hakkarainen, A., Muurinen, T., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606592 · Cited by 76
Self-citationDELETIONS OF MUSCLE MITOCHONDRIAL DNA
Holt, I. J., Cooper, J. A. D., MORGAN-HUGHES, J. A., & Harding, A. E. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92273-8 · Cited by 74
Nandania, J., Kokkonen, M. K., Euro, L., & Velagapudi, V. (2018) · Journal of Chromatography B · doi:10.1016/j.jchromb.2018.06.008 · Cited by 38
Self-citationNandania, J., Gopalacharyulu, P. V., Pessia, A., Kokkonen, M. K., & Velagapudi, V. (2018) · Metabolites · doi:10.3390/metabo8030044 · Cited by 34
Self-citationOllila, L., Heliö, T. M., Sovijärvi, A. R., Jalanko, M., Kaartinen, M., Kuusisto, J., Kärkkäinen, S., Jurkko, R., Reissell, E., Palojoki, E., et al. (2015) · Clinical Physiology and Functional Imaging · doi:10.1111/cpf.12260 · Cited by 8
Self-citation
Cited by
Mitochondrial DNA copy number in human disease: the more the better?
Filograna, R., Mennuni, M., Alsina, D., & Larsson, N. (2021) · FEBS Letters · doi:10.1002/1873-3468.14021 · Cited by 478
Mitochondria at the crossroads of health and disease
Suomalainen, A., & Nunnari, J. (2024) · Cell · doi:10.1016/j.cell.2024.04.037 · Cited by 478
Self-citationZhu, X., Chen, Z., Shen, W., Huang, G., Sedivy, J. M., Wang, H., & Ju, Z. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00646-9 · Cited by 393
Evolving concepts in NAD+ metabolism
Chini, C. C. S., Zeidler, J. D., Kashyap, S., Warner, G., & Chini, E. N. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.04.003 · Cited by 288
NAD + Metabolism in Cardiac Health, Aging, and Disease
Abdellatif, M., Sedej, S., & Kroemer, G. (2021) · Circulation · doi:10.1161/circulationaha.121.056589 · Cited by 255
Metadata
- Authors
- Pirinen, E., Auranen, M., Khan, N. A., Brilhante, V., Urho, N., Pessia, A., Hakkarainen, A., Kuula, J., Heinonen, U., Schmidt, M. S., Haimilahti, K., Piirilä, P., Lundbom, N., Taskinen, M.-R., Brenner, C., Velagapudi, V., Pietiläinen, K. H., & Suomalainen, A.
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2020-06
- Volume
- 31
- Issue
- 6
- Pages
- 1078-1090.e5
- ISSN
- 1550-4131 (ISSN-L)
- OpenAlex
- W3022810443
- Cited by
- 278
- References
- 67
- FWCI
- 16.69
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.